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background:  Recent guidelines propose the use of the Atherosclerotic Cardiovascular Disease score (ASCVD) to assess an individual’s 
risk of future cardiovascular disease (CVD) events. However, few data exist on the predictive utility of the ASCVD score in the metabolic 
syndrome patients.
Methods:  Multi-Ethnic Study of Atherosclerosis (MESA) is a population based study (n=6,814) of White (38%), Black (28%), Chinese 
(22%) and Hispanic (12%) subjects, aged 45-84 years, free from clinical cardiovascular disease. We performed an analysis of 6,742 
participants (mean age 62, 53% female) from the MESA cohort. The ASCVD score was calculated for each participant. Models including 
ASCVD score with and without CACS were compared for those with and without the metabolic syndrome for CVD risk prediction.
Results:  See table 1.
conclusion:  Predictive performance of ASCVD score weakened among those with metabolic syndrome. CACS significantly improved risk 
reclassification for CVD events regardless of their metabolic syndrome status.
Table 1: Analytic Properties of ASCVD Score* With and Without Coronary Calcium Score for Prediction of Cardiovascular Disease Events©
Metabolic Syndrome
Yes No
Number of Patients/ Events 2422/ 173 4320/ 153
Event Rate [per 1000 person-years] 7.1% 3.5%
Discrimination
C Statistic for ASCVD 0.697 0.752
C Statistic for ASCVD + CACS 0.713 0.781
Improvement in C Statistic (p value) 0.017 (p=0.23) 0.029 (p=0.024)
Calibration
Hosmer-Lemeshow Chi-square (p value) 7.08 (p=0.53) 21.49 (p=0.006)
Bayes Information Criterion (BIC) support for model with CACS Very strong Very strong
Reclassification
¶Categorical NRI (p value) 0.245 (p<0.001) 0.202 (p<0.001)
Category-less NRI (p value) 0.433 (p<0.001) 0.640 (p<0.001)
Integrated Discrimination Index (p value) 0.011 (p<0.001) 0.010 (p=0.005)
Abbreviations: ASCVD = Atherosclerotic cardiovascular disease, CACS = Coronary artery calcium score; NRI = Net reclassification index,
*ASCVD risk score was calculated in compliance with pooled cohort equation provided by American College of Cardiology/ American 
Heart Association guidelines which incorporated gender and ethnicity based risk estimated incorporating following risk factors: age, 
total cholesterol, high density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, diabetes, current smoking. For 
Chinese and Hispanic Americans, risk estimates of Caucasian Americans were assigned as suggested by the guidelines.
©CVD events included myocardial infarction, death due to myocardial infarction, resuscitated cardiac arrest, stroke, and death from 
stroke.
¶In calculation of categorical NRI, risk categories for ASCVD score were re-calibrated to provide corresponding risk estimates for 7 years 
follow-up.
The interaction between the metabolic syndrome and ASCVD for prediction of CVD events was statistically significant (p=0.009)
